Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.00% | 204.73 | 0.0% | $1981.02m | |
| NVAX | Novavax, Inc. | 0.00% | 110.82 | 78.2% | $792.93m | |
| BIIB | Biogen, Inc. | 0.00% | 239.30 | 1.8% | $522.63m | |
| AMGN | Amgen, Inc. | 0.00% | 235.36 | 1.4% | $522.04m | |
| BNTX | BioNTech SE | 0.00% | 196.00 | 0.0% | $501.82m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 71.77 | 1.0% | $472.12m | |
| ILMN | Illumina, Inc. | 0.00% | 405.14 | 3.3% | $406.87m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 615.24 | 2.7% | $388.21m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.00% | 234.06 | 1.9% | $331.63m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 3.17 | 0.7% | $221.59m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 78.43 | 17.9% | $151.61m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.00% | 148.50 | 8.2% | $151.18m | |
| ARNA | Arena Pharmaceuticals, Inc. | 0.00% | 92.65 | 13.7% | $144.29m | |
| INCY | Incyte Corp. | 0.00% | 74.88 | 2.4% | $128.10m | |
| BBIO | BridgeBio Pharma, Inc. | 0.00% | 12.75 | 0.0% | $115.66m |
Company Profile
Sio Gene Therapies Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. Its product pipeline focus on Parkinson's Disease, GM1 gangliosidosis, and GM2 gangliosidosis such as Tay-Sachs disease and Sandhoff disease. The company was founded on October 31, 2014 and is headquartered in New York, NY.